A study on breast cancer revealed that an ICOSL+ B cell subset emerges after chemotherapy; this subset is linked to a better prognosis, and it can promote the proliferation of tumor-specific T cells while reducing regulatory T cells (Tregs) [24]. The gene discussed is ICOSLG; the disease is breast cancer.